Free tool
Stocks above their 200-day average
We cover 165 companies trading above their own 200-day average. The median market value in the group is $82.41M. Across the group, the median move over the past trading day is +0.62%. 100% of the 165 with a 200-day average trade above it. Price change over the past year runs from −25.1% to +76.8% across the middle 80 percent of the group, with a median of +13.2%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
165 of 10,735 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | $1.07T | Mega cap | +73.55% |
| JNJ.DE | Johnson & Johnson | $651.71B | Mega cap | +58.93% |
| 4AB.DE | AbbVie Inc. | $471.29B | Mega cap | +32.34% |
| 6MK.DE | Merck & Co., Inc. | $379.64B | Mega cap | +91.49% |
| RHO.DE | Roche Holding AG | $370.84B | Mega cap | +41.42% |
| NOT.DE | Novartis AG | $300.14B | Mega cap | +28.89% |
| AMG.DE | Amgen Inc. | $237.76B | Mega cap | +60.12% |
| TN8.DE | Thermo Fisher Scientific Inc. | $234.00B | Mega cap | +29.67% |
| NVO.WA | Novo Nordisk A/S | $212.23B | Mega cap | −9.22% |
| NOVO-B.CO | Novo Nordisk A/S | $210.20B | Mega cap | −11.26% |
| NOV.DE | Novo Nordisk A/S | $209.27B | Mega cap | +15.22% |
| ABL.DE | Abbott Laboratories | $200.44B | Mega cap | −10.02% |
| GIS.DE | Gilead Sciences, Inc. | $184.35B | Large cap | +33.64% |
| PFE.DE | Pfizer Inc. | $161.11B | Large cap | +22.96% |
| DAP.DE | Danaher Corporation | $151.59B | Large cap | +6.90% |
| VX1.DE | Vertex Pharmaceuticals Incorporated | $139.82B | Large cap | +41.64% |
| BRM.DE | Bristol-Myers Squibb Company | $137.92B | Large cap | +50.84% |
| 2M6.DE | Medtronic plc | $117.57B | Large cap | +2.65% |
| MRK.DE | Merck KGaA | $70.28B | Large cap | +32.17% |
| 0QF.DE | Moderna, Inc. | $59.07B | Large cap | +550.51% |
| BAYN.DE | Bayer Aktiengesellschaft | $56.25B | Large cap | +76.91% |
| BAY.WA | Bayer Aktiengesellschaft | $55.90B | Large cap | +76.59% |
| EWL.DE | Edwards Lifesciences Corporation | $52.39B | Large cap | +11.65% |
| BOX.DE | Becton, Dickinson and Company | $51.84B | Large cap | +1.73% |
| SHL.DE | Siemens Healthineers AG | $51.23B | Large cap | −14.18% |
| H6D0.DE | Haleon plc | $44.85B | Large cap | +5.39% |
| HLN.L | Haleon plc | $44.62B | Large cap | +2.68% |
| QTS.DE | IQVIA Holdings Inc. | $43.01B | Large cap | −4.04% |
| VEE.DE | Veeva Systems Inc. | $40.02B | Large cap | +13.43% |
| ILU.DE | Illumina, Inc. | $34.08B | Large cap | +129.80% |
| DC4.DE | DexCom, Inc. | $33.35B | Large cap | +21.06% |
| IDP.DE | Biogen Inc. | $32.39B | Large cap | +65.32% |
| FRE.DE | Fresenius SE & Co. KGaA | $30.43B | Large cap | +1.64% |
| 22UA.DE | BioNTech SE | $28.28B | Large cap | +14.09% |
| MTO.DE | Mettler-Toledo International Inc. | $27.92B | Large cap | +13.15% |
| DIM.PA | Sartorius Stedim Biotech S.A. | $21.78B | Large cap | +11.64% |
| 56S1.DE | Sartorius Stedim Biotech S.A. | $21.77B | Large cap | +11.32% |
| GMAB.CO | Genmab A/S | $20.69B | Large cap | +36.19% |
| GE9.DE | Genmab A/S | $20.65B | Large cap | −11.12% |
| SRT3.DE | Sartorius Aktiengesellschaft | $19.68B | Large cap | +25.88% |
| VIA.DE | Viatris Inc. | $19.41B | Large cap | +67.32% |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | $16.99B | Large cap | +61.26% |
| IPN.PA | Ipsen S.A. | $15.97B | Large cap | +40.80% |
| SRT.DE | Sartorius Aktiengesellschaft | $15.54B | Large cap | +21.79% |
| ESF0.DE | Eurofins Scientific SE | $14.67B | Large cap | +12.65% |
| ERF.PA | Eurofins Scientific SE | $14.64B | Large cap | +15.60% |
| ORNBV.HE | Orion Oyj | $13.16B | Large cap | +21.01% |
| ORNAV.HE | Orion Oyj | $13.11B | Large cap | +21.27% |
| FME.DE | Fresenius Medical Care AG | $12.64B | Large cap | −2.61% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | $12.57B | Large cap | +1.80% |
| DEMANT.CO | Demant A/S | $9.36B | Mid cap | +17.12% |
| WDH1.DE | Demant A/S | $9.33B | Mid cap | −5.53% |
| KRK.WA | Krka, d. d. | $9.20B | Mid cap | +30.59% |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +20.89% |
| HLUN-B.CO | H. Lundbeck A/S | $6.47B | Mid cap | +8.99% |
| HLUN-A.CO | H. Lundbeck A/S | $6.40B | Mid cap | +29.71% |
| CTEC.L | Convatec Group PLC | $6.01B | Mid cap | −1.95% |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | −17.02% |
| HIK.L | Hikma Pharmaceuticals PLC | $4.61B | Mid cap | −9.62% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | $4.08B | Mid cap | +1.26% |
| MCOV-B.ST | Medicover AB (publ) | $3.85B | Mid cap | −8.20% |
| CAMX.ST | Camurus AB (publ) | $3.79B | Mid cap | −15.35% |
| AFX.DE | Carl Zeiss Meditec AG | $3.19B | Mid cap | −24.83% |
| BIOA-B.ST | BioArctic AB (publ) | $3.00B | Mid cap | +12.31% |
| B72.DE | AtaiBeckley Inc. | $2.79B | Mid cap | +59.69% |
| AMBU-B.CO | Ambu A/S | $2.69B | Mid cap | −19.13% |
| BV3.DE | Bavarian Nordic A/S | $2.55B | Mid cap | +15.65% |
| BAVA.CO | Bavarian Nordic A/S | $2.51B | Mid cap | −7.97% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.45B | Mid cap | +70.53% |
| ONT.L | Oxford Nanopore Technologies plc | $2.41B | Mid cap | −2.24% |
| DMP.DE | Dermapharm Holding SE | $2.31B | Mid cap | +27.27% |
| EKTA-B.ST | Elekta AB (publ) | $2.20B | Mid cap | +26.10% |
| ALIF-B.ST | AddLife AB (publ) | $2.08B | Mid cap | −7.20% |
| NANO.PA | Nanobiotix S.A. | $2.05B | Mid cap | +358.21% |
| NANOFH.HE | Nanoform Finland Oyj | $95.78M | Micro cap | +15.66% |
| NANOFS.ST | Nanoform Finland Oyj | $93.63M | Micro cap | +19.56% |
| BIOPOR.CO | BioPorto A/S | $93.40M | Micro cap | −3.13% |
| IBT-B.ST | Infant Bacterial Therapeutics AB (publ) | $91.93M | Micro cap | +15.88% |
| EAH.L | ECO Animal Health Group plc | $89.77M | Micro cap | +34.69% |
| NANEXA.ST | Nanexa AB (publ) | $87.59M | Micro cap | +100.43% |
| ALZCUR.ST | AlzeCure Pharma AB (publ) | $86.56M | Micro cap | +78.27% |
| CREO.L | Creo Medical Group PLC | $85.82M | Micro cap | −1.90% |
| POLB.L | Poolbeg Pharma PLC | $82.41M | Micro cap | +164.62% |
| HIGH.DE | Cantourage Group SE | $81.55M | Micro cap | +51.90% |
| OBI.L | Ondine Biomedical Inc. | $81.20M | Micro cap | −24.19% |
| INIFY.OL | INIFY Laboratories AB | $81.09M | Micro cap | +44.55% |
| KOO.L | Kooth plc | $72.00M | Micro cap | −7.59% |
| ALTHX.PA | THX Pharma Société Anonyme | $71.22M | Micro cap | +73.96% |
| ZLNA.OL | Zelluna ASA | $70.31M | Micro cap | +56.57% |
| SAR.L | Sareum Holdings plc | $70.10M | Micro cap | +76.19% |
| R0L.F | J Frontier Co.,Ltd. | $64.05M | Micro cap | −44.02% |
| ALTHE.PA | Theraclion SA | $55.29M | Micro cap | −22.30% |
| ALSMA.PA | S.M.A.I.O S.A. | $54.96M | Micro cap | +14.29% |
| EPIS-B.ST | Episurf Medical AB (publ) | $53.85M | Micro cap | +71.52% |
| OHGR.L | One Health Group Plc | $53.82M | Micro cap | +17.03% |
| MOB.ST | Moberg Pharma AB (publ) | $53.40M | Micro cap | +32.92% |
| IMMU.ST | Mendus AB (publ) | $46.19M | Micro cap | −4.57% |
| CLBIO.ST | Corline Biomedical AB | $45.27M | Micro cap | +45.56% |
| ONCIN.OL | Oncoinvent ASA | $43.71M | Micro cap | +10.90% |
| ALCOX.PA | Nicox S.A. | $43.02M | Micro cap | +2.70% |
| ALNOV.PA | Novacyt S.A. | $42.69M | Micro cap | +7.38% |
| NCYT.L | Novacyt S.A. | $42.07M | Micro cap | +7.81% |
| IVACC.ST | Intervacc AB (publ) | $38.50M | Micro cap | +4.78% |
| ALMKT.PA | Mauna Kea Technologies SA | $37.11M | Micro cap | +47.33% |
| ABDX.L | Abingdon Health Plc | $36.92M | Micro cap | +104.76% |
| SPRINT.ST | Sprint Bioscience AB (publ) | $35.56M | Micro cap | +458.51% |
| ALGEN.PA | genOway Société anonyme | $35.25M | Micro cap | −18.00% |
| BIOWKS.ST | Bio-Works Technologies AB (publ) | $35.21M | Micro cap | +4.75% |
| PTG.WA | Poltreg S.A. | $34.78M | Micro cap | −14.68% |
| PXS.L | Provexis plc | $32.52M | Micro cap | +51.39% |
| BRAIN.ST | BrainCool AB (publ) | $32.34M | Micro cap | −21.51% |
| SIGHT.PA | GenSight Biologics S.A. | $32.26M | Micro cap | −25.31% |
| ALDVI.PA | Advicenne S.A. | $30.93M | Micro cap | +39.11% |
| GDR.L | genedrive plc | $28.91M | Micro cap | +67.74% |
| NN6.DE | NanoRepro AG | $27.65M | Micro cap | −4.90% |
| IRLAB-A.ST | IRLAB Therapeutics AB (publ) | $27.48M | Micro cap | −44.31% |
| SOFTX.OL | SoftOx Solutions AS | $27.33M | Micro cap | −15.04% |
| ISOFOL.ST | Isofol Medical AB (publ) | $26.92M | Micro cap | −1.87% |
| KLAR.ST | Klaria Pharma Holding AB (publ.) | $26.60M | Micro cap | +97.38% |
| RENX.L | Renalytix Plc | $25.24M | Micro cap | −26.50% |
| INTEG-B.ST | Integrum AB (publ) | $24.72M | Micro cap | −79.55% |
| RUA.L | RUA Life Sciences plc | $24.04M | Micro cap | +130.93% |
| ALTAO.PA | Aton | $22.75M | Micro cap | +153.85% |
| DEX.ST | Dextech Medical AB | $20.09M | Micro cap | +26.38% |
| CLBX.L | CelLBxHealth plc | $19.30M | Micro cap | −79.17% |
| ALBIO.PA | Biosynex SA | $19.25M | Micro cap | −23.23% |
| ALINS.PA | Intrasense S.A. | $18.05M | Micro cap | −0.34% |
| ALTME.PA | TME Pharma N.V. | $17.97M | Micro cap | +25.97% |
| ALZ.ST | Alzinova AB (publ) | $17.74M | Micro cap | −39.02% |
| ABERA.ST | Abera Bioscience AB | $17.69M | Micro cap | +1.61% |
| HEART.ST | Scandinavian Real Heart AB (Publ) | $17.00M | Micro cap | +3.31% |
| ALEMG.PA | Laboratoires Euromedis Société anonyme | $16.52M | Micro cap | +18.10% |
| THAT.L | Thalia Therapeutics Plc | $15.69M | Micro cap | +52.94% |
| ORTI-B.ST | Ortivus AB (publ) | $15.21M | Micro cap | +42.11% |
| ACTI.ST | Active Biotech AB (publ) | $14.50M | Micro cap | −62.00% |
| OBSRV.OL | Observe Medical ASA | $14.28M | Micro cap | +5.05% |
| BIOVIC-B.ST | Biovica International AB (publ) | $13.67M | Micro cap | −30.12% |
| SIMRIS-B.ST | Simris Group AB (PUBL) | $13.60M | Micro cap | −28.35% |
| ICO.ST | Iconovo AB (publ) | $12.72M | Micro cap | −52.09% |
| NXTCL.ST | NextCell Pharma AB | $12.42M | Micro cap | −5.10% |
| CRTX.L | CRISM Therapeutics Corporation | $12.38M | Micro cap | +9.52% |
| ARCOMA.ST | Arcoma AB | $12.17M | Micro cap | −2.13% |
| ALBPS.PA | Biophytis S.A. | $11.98M | Micro cap | −50.31% |
| ALAMA.PA | AMA Corporation Plc | $10.27M | Micro cap | −34.56% |
| IDLDX.ST | IDL Diagnostics AB (publ) | $9.63M | Micro cap | −2.36% |
| NEWBRY.ST | Newbury Pharmaceuticals AB (publ) | $8.30M | Micro cap | −0.39% |
| PRE.MI | Predict S.p.A. | $8.17M | Micro cap | +7.51% |
| PILA.ST | Pila Pharma AB (publ) | $7.79M | Micro cap | −15.41% |
| CODE.OL | CodeLab Capital AS | $7.42M | Micro cap | +22.74% |
| MODTX.ST | Modus Therapeutics Holding AB (publ) | $6.35M | Micro cap | −85.49% |
| PEXA-B.ST | PExA AB (publ) | $6.18M | Micro cap | +79.47% |
| STRAP.CO | Strategic Partners A/S | $5.82M | Micro cap | −28.50% |
| SERV.ST | Servana AB | $5.18M | Micro cap | +106.67% |
| FLUI.ST | Fluicell AB (publ) | $5.06M | Micro cap | +247.74% |
| AINO.ST | Aino Health AB (publ) | $4.25M | Micro cap | −10.81% |
| DBP-B.ST | Double Bond Pharmaceutical International AB (publ) | $3.53M | Micro cap | +11.79% |
| PYC.L | Physiomics Plc | $3.17M | Micro cap | +21.18% |
| MONSO.CO | Monsenso A/S | $3.14M | Micro cap | +23.81% |
| SPERM.ST | Spermosens AB (publ) | $3.13M | Micro cap | +15.79% |
| PHAL.ST | PharmaLundensis AB | $2.14M | Micro cap | +37.83% |
| RESP.ST | Respiratorius AB (publ) | $1.89M | Micro cap | −39.20% |
| 27N0.DE | Cannovum Cannabis AG | $1.71M | Micro cap | +22.47% |
| BIG1.DE | Bio-Gate AG | $1.55M | Micro cap | +200.53% |
| ALINT.PA | IntegraGen SA | $1.38M | Micro cap | −36.25% |
| ALNEV.PA | Neovacs S.A. | $22.00 | Micro cap | −11.29% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.